RBA Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$229K Buy
+544
New +$217K 0.07% 109
2021
Q3
– Sell
-890
Closed -$217K – 22
2021
Q2
$217K Sell
890
-1
-0.1% -$246 0.46% 23
2021
Q1
$222K Buy
+891
New +$213K 0.19% 58
2020
Q4
– Sell
-979
Closed -$249K – 100
2020
Q3
$249K Hold
979
– – 0.17% 92
2020
Q2
$231K Buy
+979
New +$223K 0.17% 93
2020
Q1
– Sell
-1,100
Closed -$264K – 95
2019
Q4
$264K Sell
1,100
-5
-0.5% -$1.1K 0.18% 89
2019
Q3
$214K Sell
1,105
-50
-4% -$9.6K 0.16% 95
2019
Q2
$213K Sell
1,155
-130
-10% -$23.3K 0.16% 83
2019
Q1
$249K Hold
1,285
– – 0.19% 72

Other funds holding AMGN

RBA Wealth Management's AMGN Position: Q3 2026 in Review

RBA Wealth Management opened a new position in Amgen (AMGN) in Q3 2026: 544 shares worth $229K. The stake represents 0.07% of the portfolio and ranks #109 among its holdings. This is a return to the name: RBA Wealth Management previously reported a position in AMGN as recently as Q2 2021.

RBA Wealth Management first reported a position in AMGN in Q1 2019 and has held it in 9 quarters since. The position peaked at $264K in Q4 2019. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • RBA Wealth Management held 544 shares of Amgen worth $229K as of Q3 2026.
  • Amgen was a new RBA Wealth Management position in Q3 2026.
  • Amgen made up 0.07% of RBA Wealth Management's portfolio in Q3 2026, its #109 holding.
  • RBA Wealth Management first reported a position in Amgen in Q1 2019 and has held it in 9 quarters since.
  • RBA Wealth Management's Amgen position peaked at $264K in Q4 2019.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on RBA Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.